Clomiphene Citrate (CC)/Gonadotropin/Gonadotropin Releasing Hormone (GnRH) Antagonist Versus Gonadotropin/GnRH Agonist
Launched by YAZD RESEARCH & CLINICAL CENTER FOR INFERTILITY · Jan 27, 2009
Trial Information
Current as of June 21, 2025
Completed
Keywords
ClinConnect Summary
No description provided
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • female patient age 18-35 years, presence of a regular and proven ovulatory menstruation cycle with a length of 26-35 days
- • basal FSH \<10 IU/L and body mass index (BMI) of 18-30 (kg/m²)
- • Indication for IVF were unexplained infertility, mild male factor, tubal factor, early stage endometriosis and cervical factor
- Exclusion Criteria:
- • patient requiring ICSI
About Yazd Research & Clinical Center For Infertility
Yazd Research & Clinical Center for Infertility is a leading institution dedicated to advancing reproductive health through innovative research and clinical excellence. Situated in Yazd, Iran, the center specializes in the diagnosis and treatment of infertility, leveraging cutting-edge technologies and evidence-based practices to improve patient outcomes. With a commitment to scientific inquiry and patient care, the center conducts rigorous clinical trials aimed at enhancing reproductive techniques and expanding treatment options for individuals and couples facing infertility challenges. Its multidisciplinary team of experts collaborates to ensure the highest standards of care while contributing valuable insights to the field of reproductive medicine.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Yazd, , Iran, Islamic Republic Of
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials